Paul W. Burridge, Ph.D.
Affiliations: | 2015- | Pharmacology | Northwestern University Medical School, Chicago, IL, United States |
Area:
Pharmacogenomics, stem cells, cardiovascular diseasesWebsite:
https://labs.feinberg.northwestern.edu/burridge/Google:
"Paul Burridge"Mean distance: (not calculated yet)
Parents
Sign in to add mentorChris Denning | grad student | 2008 | Nottingham |
Roger Patient | grad student | 2008 | Oxford University UK |
Lorraine Young | grad student | 2008 | Nottingham |
Elias Zambidis | post-doc | 2009-2011 | Johns Hopkins Medical School |
Joseph C. Wu | post-doc | 2011-2013 | Stanford University Medical School (Physics Tree) |
Children
Sign in to add traineeTarek Magdy Mohamed | post-doc | 2015- | Northwestern University Medical School |
Mariam Jouni | post-doc | 2018- | Northwestern University Medical School |
Hananeh Fonoudi | post-doc | 2019- | Northwestern University Medical School |
Davi Marco Lyra-Leite | post-doc | 2019- | Northwestern University Medical School |
Malorie Nicole Marcelle | post-doc | 2019- | Northwestern University Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lyra-Leite DM, Gutiérrez-Gutiérrez Ó, Wang M, et al. (2022) A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming. Star Protocols. 3: 101560 |
Barc J, Tadros R, Glinge C, et al. (2022) Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. Nature Genetics |
Barc J, Tadros R, Glinge C, et al. (2022) Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. Nature Genetics |
Magdy T, Jouni M, Kuo HH, et al. (2021) Identification of Drug Transporter Genomic Variants and Inhibitors that Protect Against Doxorubicin-Induced Cardiotoxicity. Circulation |
Magdy T, Jiang Z, Jouni M, et al. (2021) RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy. Cell Stem Cell |
Marchal GA, Jouni M, Chiang DY, et al. (2021) Targeting the Microtubule EB1-CLASP2 Complex Modulates Na1.5 at Intercalated Discs. Circulation Research |
Lyra-Leite DM, Fonoudi H, Gharib M, et al. (2021) An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cells. Star Protocols. 2: 100213 |
Magdy T, Burridge PW. (2021) Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicity. Pharmacogenomics. 22: 41-54 |
Fonoudi H, Lyra-Leite DM, Javed HA, et al. (2021) Generating a Cost-Effective, Weekend-Free Chemically Defined Human Induced Pluripotent Stem Cell (hiPSC) Culture Medium. Current Protocols in Stem Cell Biology. 53: e110 |
Magdy T, Burridge PW. (2021) Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicity Pharmacogenomics. 22: 41-54 |